This effect is achieved by activating the Akt signaling pathway through the interaction of COL11A1 with DDR2 receptor tyrosine kinase and α1β1 integrin on the cell surface of ovarian cancer cells. The gene discussed is AKT1; the disease is ovarian carcinoma.